3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoro-1-octanol
Names
[ CAS No. ]:
647-42-7
[ Name ]:
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoro-1-octanol
[Synonym ]:
1-Octanol, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctan-1-ol
MFCD00042143
1H,1H,2H,2H-Perfluorooctan-1-ol
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoro-1-octanol
EINECS 211-477-1
1H,1H,2H,2H-Perfluorooctanol
1H, 1H, 2H, 2H-Perfluorooctan-1-ol
Chemical & Physical Properties
[ Density]:
1.6±0.1 g/cm3
[ Boiling Point ]:
174.1±0.0 °C at 760 mmHg
[ Molecular Formula ]:
C8H5F13O
[ Molecular Weight ]:
364.104
[ Flash Point ]:
91.7±0.0 °C
[ Exact Mass ]:
364.013275
[ PSA ]:
20.23000
[ LogP ]:
4.16
[ Vapour Pressure ]:
0.4±0.7 mmHg at 25°C
[ Index of Refraction ]:
1.298
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
Xi:Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S37/39
[ RIDADR ]:
NA 1993 / PGIII
[ WGK Germany ]:
1
[ HS Code ]:
2905590090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2905590090
[ Summary ]:
2905590090 other halogenated, sulphonated, nitrated or nitrosated derivatives of acyclic alcohols。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0%
Articles
Biotechnol. Biofuels 8 , 193, (2015)
Photosynthetic cyanobacteria are attractive for a range of biotechnological applications including biofuel production. However, due to slow growth, screening of mutant libraries using microtiter plate...
Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.Biomicrofluidics 9 , 052601, (2015)
The poor solubility of many newly discovered drugs has resulted in numerous challenges for the time-controlled release of therapeutics. In this study, an advanced drug delivery platform to encapsulate...